Target intelligence / Profile preview

Serine-aspartate repeat-containing protein G (SdrG)

Target
SdrG
Molecular classification
Adhesin (bacterial surface protein), Other (not a receptor, enzyme, transporter, or transcription factor)
01

Overview

Serine-aspartate repeat-containing protein G (SdrG) is a cell-surface adhesin found in certain Gram-positive bacteria such as *Staphylococcus epidermidis* and *Staphylococcus aureus*. It plays a key role in bacterial pathogenesis by binding specifically to the N-terminal region of the B beta-chain of human fibrinogen. This interaction interferes with thrombin-mediated cleavage and release of fibrinopeptide B from fibrinogen. SdrG also mediates weak homophilic bonds between bacterial cells that facilitate biofilm formation on surfaces such as indwelling medical devices. These properties make it an important virulence factor contributing to infection persistence and immune evasion. Experimental studies have shown that peptides derived from β-neurexin can inhibit SdrG-mediated adhesion and biofilm accumulation[5][7].

Other names
SdrGserine-aspartate repeat protein Gserine-aspartate dipeptide repeat protein G
02

Mechanism of action

Binds to the N-terminal region of the B beta-chain of human fibrinogen, interfering with thrombin cleavage and release of fibrinopeptide B. Mediates homophilic interactions that promote cell–cell adhesion in biofilms. Can be inhibited by peptides derived from β-neurexin that block its adhesive functions.

03

Biological functions

Cell adhesion (mediates bacterial attachment to host proteins)Biofilm formationImmune evasion (by interfering with host coagulation processes)
04

Disease associations

Infection (notably in device-associated and bloodstream infections by Staphylococcus species)Other (biofilm-related pathogenesis)
05

Safety considerations

No direct safety concerns for targeting SdrG itselfInhibition could theoretically impact normal host-microbe interactions or select for resistant strains
06

Interacting drugs

Experimental peptide inhibitors
07

Biomarkers

None established for clinical use

Beyond the preview

Go deeper on Serine-aspartate repeat-containing protein G (SdrG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine-aspartate repeat-containing protein G (SdrG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call